BRPI0806263A2 - Uso de um composto avermectin e composição para aplicação tópica compreendendo um composto avermectin - Google Patents

Uso de um composto avermectin e composição para aplicação tópica compreendendo um composto avermectin Download PDF

Info

Publication number
BRPI0806263A2
BRPI0806263A2 BRPI0806263-3A BRPI0806263A BRPI0806263A2 BR PI0806263 A2 BRPI0806263 A2 BR PI0806263A2 BR PI0806263 A BRPI0806263 A BR PI0806263A BR PI0806263 A2 BRPI0806263 A2 BR PI0806263A2
Authority
BR
Brazil
Prior art keywords
avermectin compound
bite
avermectin
compound
composition understanding
Prior art date
Application number
BRPI0806263-3A
Other languages
English (en)
Inventor
Jeffrey D Parks
L Dean Parks
Original Assignee
Jeffrey D Parks
L Dean Parks
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jeffrey D Parks, L Dean Parks filed Critical Jeffrey D Parks
Publication of BRPI0806263A2 publication Critical patent/BRPI0806263A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Saccharide Compounds (AREA)

Abstract

USO DE UM COMPOSTO AVERMECTIN E COMPOSIçãO PARA APLICAçãO TóPICA COMPREENDENDO UM COMPOSTO AVERMECTIN. A presente invenção refere-se a um método de tratamento de hiperestesia, parestesia, dor e prurido causados pela picada ou mordida de um inseto ou artrópodo ou contato da pele com uma erva-daninha ou planta nociva é descrito, O método inclui aplicar topicamente uma composição dermatológica contendo um composto avermectina a uma área afetada imediatamente após a dita picada ou mordida ou dito contato com a pele ocorrer. O método inclui ainda umedecimento da área afetada primeiro antes da aplicação da composição dermatológica.
BRPI0806263-3A 2007-01-03 2008-01-02 Uso de um composto avermectin e composição para aplicação tópica compreendendo um composto avermectin BRPI0806263A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11/648,941 US8901163B2 (en) 2007-01-03 2007-01-03 Method of treating hyperesthesia, paresthesia, dolor, and pruritus caused by insect stings or noxious weeds or plants using avermectin compound
PCT/US2008/000007 WO2008085808A2 (en) 2007-01-03 2008-01-02 Method of treating hyperesthesia, paresthesia, dolor, and pruritus caused by insect stings or noxious weeds or plants using avermectin compound

Publications (1)

Publication Number Publication Date
BRPI0806263A2 true BRPI0806263A2 (pt) 2011-08-30

Family

ID=39584879

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0806263-3A BRPI0806263A2 (pt) 2007-01-03 2008-01-02 Uso de um composto avermectin e composição para aplicação tópica compreendendo um composto avermectin

Country Status (14)

Country Link
US (2) US8901163B2 (pt)
EP (1) EP2101756B1 (pt)
JP (2) JP5200248B2 (pt)
BR (1) BRPI0806263A2 (pt)
CA (1) CA2674379C (pt)
CY (1) CY1114236T1 (pt)
DK (1) DK2101756T3 (pt)
ES (1) ES2421199T3 (pt)
HR (1) HRP20130581T1 (pt)
MX (1) MX2009007132A (pt)
PL (1) PL2101756T3 (pt)
PT (1) PT2101756E (pt)
SI (1) SI2101756T1 (pt)
WO (1) WO2008085808A2 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3070857B1 (fr) * 2017-09-11 2019-09-06 Centre Scientifique De Monaco Utilisation de la scleritine en tant qu'agent protecteur de cellules contre des agents toxiques
BE1027141B1 (nl) 2019-08-30 2020-10-15 Oystershell Nv Polyisobuteen voor gebruik bij behandeling of preventie van infectie door geleedpotigen
WO2023180957A1 (en) * 2022-03-22 2023-09-28 Equilibre Biopharmaceuticals Bv Methods of using avermectin compositions for the treatment of pain and dosing regimens

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE434277B (sv) 1976-04-19 1984-07-16 Merck & Co Inc Sett att framstella nya antihelmintiskt verkande foreningar genom odling av streptomyces avermitilis
US4199569A (en) 1977-10-03 1980-04-22 Merck & Co., Inc. Selective hydrogenation products of C-076 compounds and derivatives thereof
US4206205A (en) 1977-10-03 1980-06-03 Merck & Co., Inc. Monosaccharide and aglycone derivatives of C-076
US4201861A (en) 1977-10-03 1980-05-06 Merck & Co., Inc. Acyl derivatives of C-076 compounds
US4173571A (en) 1977-12-19 1979-11-06 Merck & Co., Inc. 13-Halo and 13-deoxy derivatives of C-076 compounds
US4171314A (en) 1977-12-19 1979-10-16 Merck & Co., Inc. 13-Halo and 13-deoxy C-076 compounds
US4333925A (en) 1981-05-11 1982-06-08 Merck & Co., Inc. Derivatives of C-076 compounds
US4963667A (en) 1987-11-10 1990-10-16 Merck & Co., Inc. Ivermectin derivative compounds and process for preparing the same
NZ232422A (en) 1989-02-16 1992-11-25 Merck & Co Inc 13-ketal milbemycin derivatives and parasiticides
US5055454A (en) 1989-10-30 1991-10-08 Merck & Co., Inc. 13-epi-avermectin derivatives useful as antiparasitic agents
US5830875A (en) 1989-10-30 1998-11-03 Merck & Co., Inc. 24-and 25-substituted avermectin and milbemycin derivatives
US5114930A (en) 1990-05-14 1992-05-19 Merck & Co., Inc. Avermectin derivatives with a spacer inserted between the disaccharide and the aglycone useful as antiparasitic agents
US5262400A (en) 1991-06-20 1993-11-16 Merck & Co., Inc. 4α-substituted avermectin derivatives
US5162363A (en) 1992-03-18 1992-11-10 Merck & Co., Inc. 23-nor-23-thia avermectin analogs are active anthelmintic agents
US5229416A (en) 1992-04-29 1993-07-20 Merck & Co., Inc. Avermectin difluoro derivatives
US5952372A (en) 1998-09-17 1999-09-14 Mcdaniel; William Robert Method for treating rosacea using oral or topical ivermectin
US6133310A (en) 1999-08-26 2000-10-17 Parks; L. Dean Method of treatment of rosacea
US6319945B1 (en) 2000-06-29 2001-11-20 L. Dean Parks Method of treatment of seborrheic dermatitis
US6399652B1 (en) 2000-06-29 2002-06-04 L. Dean Parks Method of treating acne vulgaris using avermectin compound
US7897559B2 (en) * 2000-06-29 2011-03-01 Parks L Dean Dermatological composition and kit containing avermectin compound for treating dermatological conditions
US6399651B1 (en) 2000-06-29 2002-06-04 L. Dean Parks Method of treating dermatoses using avermectin compound
PL378932A1 (pl) * 2003-04-24 2006-06-12 Galderma S.A. Zastosowanie ivermectiny do leczenia schorzeń dermatologicznych
FR2867684B1 (fr) * 2004-03-18 2006-05-05 Galderma Sa Gel creme contenant de l'ivermectine

Also Published As

Publication number Publication date
EP2101756B1 (en) 2013-04-10
MX2009007132A (es) 2009-07-24
PT2101756E (pt) 2013-06-27
US9662346B2 (en) 2017-05-30
CA2674379C (en) 2012-08-21
US20080161384A1 (en) 2008-07-03
EP2101756A2 (en) 2009-09-23
ES2421199T3 (es) 2013-08-29
CA2674379A1 (en) 2008-07-17
PL2101756T3 (pl) 2013-08-30
JP5200248B2 (ja) 2013-06-05
JP2012236859A (ja) 2012-12-06
JP5467132B2 (ja) 2014-04-09
US20150045315A1 (en) 2015-02-12
EP2101756A4 (en) 2010-01-06
US8901163B2 (en) 2014-12-02
WO2008085808A3 (en) 2008-09-18
HRP20130581T1 (hr) 2013-07-31
JP2010514840A (ja) 2010-05-06
SI2101756T1 (sl) 2013-11-29
DK2101756T3 (da) 2013-07-01
WO2008085808A2 (en) 2008-07-17
CY1114236T1 (el) 2016-08-31

Similar Documents

Publication Publication Date Title
BR112013015498A2 (pt) formulação localizada tópica, uso da formulação, e, método para tratamento ou profilaxia de infestação de parasita de um animal
BRPI0905941A2 (pt) Método para melhorar a saúde de uma planta uso de uma amida, misturas fungicidas, método de controle de pragas e semente
BRPI0816214B8 (pt) uso cosmético, composição cosmética e/ou dermatológica, e, métodos para o tratamento cosmético da pele, para o tratamento cosmético de sinais cutâneos de envelhecimento e/ou fotoenvelhecimento e para o tratamento cosmético para prevenir e/ou tratar substâncias queratinosas secas
ECSP11011278A (es) Composición farmacéutica que comprende derivados de glucopiranosil difenilmetano, forma farmacéutica de la misma, procedimiento para su preparación y usos de la misma para el control glucémico mejorado en un paciente.
BRPI0709581A8 (pt) compostos de bicicloeteroarila como moduladores de px27 e seu uso
CO6390030A2 (es) Sellador de teta intramamario
WO2012050745A3 (en) Compositions containing zinc pca and anogeissus extract
BR112013023897A2 (pt) método para intensificar o crescimento vegetal em angiosperma com via de resposta à auxina
DOP2007000043A (es) Derivados de cromanol sustituidos y su uso
NO20093556L (no) Fremgangsmate for bekjempelse av fiskelus
WO2011143171A3 (en) Compositions containing dna repair enzyme and anogeissus extract
MX2009007206A (es) Mezclas de pesticidas.
BR112012012042A2 (pt) composição e método para controlar pragas artrópodes.
WO2010065194A3 (en) Compositions and methods for promoting a relaxation state
BRPI0806263A2 (pt) Uso de um composto avermectin e composição para aplicação tópica compreendendo um composto avermectin
WO2009027382A3 (de) Sprühfähige zusammensetzung enthaltend extrakt aus rotem weinlaub
CR10954A (es) Mezclas pesticidas
BRPI0820815A2 (pt) composição de uso tópico contendo desbiobiotina e seus derivados e um método para tratamento da pele
AR083215A1 (es) Combinacion sinergica de abamectina y bifentrina, su proceso de preparacion y uso, y metodo utilizando la misma
WO2007144518A3 (fr) Utilisation d'un extrait de graines de mimosa dans une composition cosmetique
WO2009106555A3 (fr) Gel de sucralfate sterilise
BRPI0914462A2 (pt) "composição tópica, método de prevenção ou redução da ocorrência de tratamento de acne e uso de uma composição"
WO2008051557A3 (en) Methods and compositions for treatment of skin conditions
BR112012015590A2 (pt) "composição e método para controlar doenças de plantas"
BRPI0800753A2 (pt) composiÇÕes contendo retinàide e derivados do Ácido beta-aminoisobutÍrico

Legal Events

Date Code Title Description
B08F Application fees: dismissal - article 86 of industrial property law

Free format text: REFERENTE A 9A ANUIDADE.

B08K Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87)